Literature DB >> 21615347

Neurointensive care of patients with severe community-acquired meningitis.

M Edberg1, M Furebring, J Sjölin, P Enblad.   

Abstract

BACKGROUND: Reports about neurointensive care of severe community-acquired meningitis are few. The aims of this retrospective study were to review the acute clinical course, management and outcome in a series of bacterial meningitis patients receiving neurointensive care.
METHODS: Thirty patients (median age 51, range 1-81) admitted from a population of 2 million people during 7 years were studied. The neurointensive care protocol included escalated stepwise treatment with mild hyperventilation, cerebrospinal fluid (CSF) drainage, continuous thiopentotal infusion and decompressive craniectomy. Clinical outcome was assessed using the Glasgow outcome scale.
RESULTS: Twenty-eight patients did not respond to commands on arrival, five were non-reacting and five had dilated pupils. Twenty-two patients had positive CSF cultures: Streptococcus pneumoniae (n=18), Neisseria meningitidis (n=2), β-streptococcus group A (n=1) and Staphylococcus aureus (n=1). Thirty-five patients were mechanically ventilated. Intracranial pressure (ICP) was monitored in 28 patients (intraventricular catheter=26, intracerebral transducers=2). CSF was drained in 15 patients. Three patients received thiopentothal. Increased ICP (>20 mmHg) was observed in 7/26 patients with available ICP data. Six patients died during neurointensive care: total brain infarction (n=4), cardiac arrest (n=1) and treatment withdrawal (n=1). Seven patients died after discharge, three due to meningitis complications. At follow-up, 14 patients showed good recovery, six moderate disability, two severe disability and 13 were dead.
CONCLUSION: Patients judged to have severe meningitis should be admitted to neurointensive care units without delay for ICP monitoring and management according to modern neurointensive care principles.
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Year:  2011        PMID: 21615347     DOI: 10.1111/j.1399-6576.2011.02460.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

1.  Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.

Authors:  Kameshwar Prasad; Nirendra Kumar Rai; Amit Kumar
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis.

Authors:  Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

3.  Cerebral Metabolic Changes Related to Oxidative Metabolism in a Model of Bacterial Meningitis Induced by Lipopolysaccharide.

Authors:  M Munk; F R Poulsen; L Larsen; C H Nordström; T H Nielsen
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

4.  Invasive pressure monitoring saves from tuberculous meningitis with fulminant generalized brain edema.

Authors:  George Trendelenburg; Daniel Jussen; Steffen Grimmer; Wibke Jakob; Nicola E Hiemann; Peter Horn
Journal:  Front Neurol       Date:  2011-11-15       Impact factor: 4.003

Review 5.  What's new in bacterial meningitis.

Authors:  Matthijs C Brouwer; Eelco F M Wijdicks; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2015-09-30       Impact factor: 17.440

6.  Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study.

Authors:  Martin Glimåker; Bibi Johansson; Halla Halldorsdottir; Michael Wanecek; Adrian Elmi-Terander; Per Hamid Ghatan; Lars Lindquist; Bo Michael Bellander
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.